OSR Health's Nasdaq delisting appeal hearing set for Sept 29; trading suspended

OSR Holdings, Inc.

Hearing before Nasdaq Hearings Panel scheduled Sept 29, 2026 at 10:00 a.m. ET.
Trading in OSRH securities suspended since Aug 26, 2026; appeal filed Aug 25, 2026.
Hearing request stays Form 25-NSE filing, so formal delisting paused pending Panel decision.
Company to present plan to regain compliance; no assurance Panel grants continued listing.
CEO Kuk Hyoun Hwang signed 8-K; delisting risk remains if compliance not restored.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.